These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20031587)

  • 21. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
    Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
    J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EASL clinical practice guidelines for HFE hemochromatosis.
    European Association For The Study Of The Liver
    J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and spectrum of hemochromatosis mutations in Tunisia.
    Zorai A; Harteveld CL; Rachdi R; Dellagi K; Abbes S; Delbini P; Giordano PC
    Hematol J; 2003; 4(6):433-5. PubMed ID: 14671616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM; Peng H; Beutler E
    Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HFE-associated hereditary hemochromatosis.
    Alexander J; Kowdley KV
    Genet Med; 2009 May; 11(5):307-13. PubMed ID: 19444013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orchestration of iron homeostasis.
    Fleming RE; Bacon BR
    N Engl J Med; 2005 Apr; 352(17):1741-4. PubMed ID: 15858181
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of hereditary hemochromatosis.
    Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
    Semin Liver Dis; 2005 Nov; 25(4):411-9. PubMed ID: 16315135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-HFE-related hemochromatosis: the role of genetic factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L; Fernandez J
    Hepatology; 2010 Apr; 51(4):1473-4; author reply 1474. PubMed ID: 20373380
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors influencing disease phenotype and penetrance in HFE haemochromatosis.
    Rochette J; Le Gac G; Lassoued K; Férec C; Robson KJ
    Hum Genet; 2010 Sep; 128(3):233-48. PubMed ID: 20607553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 35. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?
    Födinger M; Sunder-Plassmann G
    Eur J Clin Invest; 2003 Sep; 33(9):737-9. PubMed ID: 12925029
    [No Abstract]   [Full Text] [Related]  

  • 38. Uncommon mutations and polymorphisms in the hemochromatosis gene.
    Pointon JJ; Wallace D; Merryweather-Clarke AT; Robson KJ
    Genet Test; 2000; 4(2):151-61. PubMed ID: 10953955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of genetic haemochromatosis].
    Milman NT
    Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.